Bonyf accelerates its export dynamic with the signing of two new commercial contracts in South East Asia
Ghent (Belgium), June 15, 2022, 8 a.m. ; bonyf NV (Ticker: MLBON), the oral comfort expert of news generation, announces the continuation of its geographic expansion with the signing of two major commercial contracts in the Philippines and Malaysia.
In the Philippines, bonyf is expanding its customer base with the finalization of a new commercial contract with Suhitas Pharmaceuticals Inc (“ Suhitas “). A leading importer and distributor in the Philippines of healthcare products, Suhitas has grown through strategic partnerships with leading pharmaceutical, healthcare and biotechnology companies around the world. Suhitas distributes over 200 products in the Philippines to a customer base of over 100 million people.
Suhitas will market bonyf’s superior adhesive cream under its own brand and invest heavily in product advertising to promote a long-term relationship not only with bonyf but also with its partners. It is planned to extend this commercial contract to bonyf’s star product, OlivaFix® Gold fixing cream, which contains 30% organic olive oil. This commercial contract is an important step for bonyf which allows it to expand its customer base in the Asia-Pacific region.
Mr. Hitesh Sharma, Managing Director of Suhitas indicated that he had a good experience with European companies and expressed the wish for a long-term relationship with bonyf.
bonyf increases its penetration in Malaysia with the signing of a commercial contract with Quantum Upstream Sdn Bhd (“ Quantum ), a 100% subsidiary of Big Pharmacy Group. According to its CEO, Mr. Meng Chuan Lee, the group has a turnover of 200 million euros. Quantum is the fastest growing pharmaceutical distribution group in Malaysia with an expected growth of more than 30% in 2022.
Malaysia’s population is 33 million. Health spending increased by 9.6% in 2021 to reach 13.4 billion euros, exceeding the growth rate of 6.9% in 2020. By 2025, they could grow at a compound annual growth rate of 7.6% over 5 years to reach 19.4 billion euros, according to analysts at Fitch Solutions.
Quantum has expanded its product line by adding the following bonyf products to its offering: OlivaFix® Gold Denture Adhesive Cream, Rapid Effervescent Cleansing Tablets and Nitradine® Effervescent Denture Disinfectant Tablets. In an interview with bonyf, Quantum highlighted positive customer feedback on the products, as well as the Vaseline-free formulation of OlivaFix® Gold Denture Adhesive Cream containing organic olive oil.
With its two new partnerships, allowing access to two high-potential markets, bonyf is accelerating its commercial penetration in major exports. These fast-growing markets are real growth drivers for bonyf and should contribute to a significant share of the group’s overall turnover in the future.
To propos of bonyf
Created in 1979, bonyf is specialized in the development, the production and the marketing of products state-of-the-art in particular for oral care. Bonyf’s ongoing commitment to innovation and continuous improvement enables it to make a real difference in the quality of life of people with oral conditions. The company has a design office in Liechtenstein, the renowned dental valley world, of one factory of production in Swiss and distributed his 15 products in 36 country in the world. Benefiting of 7 patents protecting of the formulations and of the products developed in internal, the band anticipates a Fort development of activity in the future, gate by a market of the care dental in growth sustained.
More information : https://bonyf.com
press relations
Jean-Pierre Bogaert CapValue
[email protected] [email protected]
+33 1 80 81 50 00